Russian sprinter Denis Galimzyanov (Katusha) has been provisionally suspended after testing positive for the banned performance-enhancing substance EPO (Erythropoietin).
He registered an Adverse Analytical Finding in an out-of-competition urine test on March 22.
25 year old Galimzyanov is seen as one of the up-and-coming sprinting talents in the peloton; he took his first win of the season at the opening stage of the Circuit de la Sarthe on April 3, before abandoning the next day after a crash, according to a team press release.
His most succesful spell came last year when he won four races, including Paris-Brussels and a Tour of Beijing stage.
Galimzyanov has the right to request the analysis of his B sample.
Related linksGalimzyanov wins final Tour of Beijing stage
Thank you for reading 5 articles this month* Join now for unlimited access
Enjoy your first month for just £1 / $1 / €1
*Read 5 free articles per month without a subscription
Join now for unlimited access
Try first month for just £1 / $1 / €1
Founded in 1891, Cycling Weekly and its team of expert journalists brings cyclists in-depth reviews, extensive coverage of both professional and domestic racing, as well as fitness advice and 'brew a cuppa and put your feet up' features. Cycling Weekly serves its audience across a range of platforms, from good old-fashioned print to online journalism, and video.
Best bicycle insurance, including what you need to know and how to compare
Wondering how to protect your pride and joy? Our helpful guide tells you all you need to know about bicycle insurance
By Hannah Bussey • Published
Five talking points from stage eleven of the Giro d’Italia 2022
The Cycling Weekly highlights package from the stage which finally saw an Italian win at the home race this year
By Luke Friend • Published